Clinical Trial Update: Comparison of Sugammadex (MK-8616/Org 25969) With Neostigmine Administered at 1-2 Post-tetanic Counts (PTCs) After Administration of Rocuronium or Vecuronium (19.4.302/P05945/MK-8616-025) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing sugammadex with neostigmine for reversal after rocuronium or vecuronium in general anesthesia, with completed status and results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia-related Outcomes

Drugs mentioned

• Neostigmine (neostigmine)
• Sugammadex (sugammadex)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Anesthesia, General | Phase 3 | Status: COMPLETED | Results posted: 2019-03-07